These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 6809941
1. Comparison of the inhibition of Escherichia coli and Lactobacillus casei dihydrofolate reductase by 2,4-diamino-5-(substituted-benzyl)pyrimidines: quantitative structure-activity relationships, X-ray crystallography, and computer graphics in structure-activity analysis. Hansch C, Li R, Blaney JM, Langridge R. J Med Chem; 1982 Jul; 25(7):777-84. PubMed ID: 6809941 [Abstract] [Full Text] [Related]
2. On the optimization of hydrophobic and hydrophilic substituent interactions of 2,4-diamino-5-(substituted-benzyl)pyrimidines with dihydrofolate reductase. Selassie CD, Li RL, Poe M, Hansch C. J Med Chem; 1991 Jan; 34(1):46-54. PubMed ID: 1899453 [Abstract] [Full Text] [Related]
3. On the structure selectivity problem in drug design. A comparative study of benzylpyrimidine inhibition of vertebrate and bacterial dihydrofolate reductase via molecular graphics and quantitative structure-activity relationships. Selassie CD, Fang ZX, Li RL, Hansch C, Debnath G, Klein TE, Langridge R, Kaufman BT. J Med Chem; 1989 Aug; 32(8):1895-905. PubMed ID: 2502631 [Abstract] [Full Text] [Related]
4. Crystallography, quantitative structure-activity relationships, and molecular graphics in a comparative analysis of the inhibition of dihydrofolate reductase from chicken liver and Lactobacillus casei by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(substituted-phenyl)-s-triazine s. Hansch C, Hathaway BA, Guo ZR, Selassie CD, Dietrich SW, Blaney JM, Langridge R, Volz KW, Kaufman BT. J Med Chem; 1984 Feb; 27(2):129-43. PubMed ID: 6420569 [Abstract] [Full Text] [Related]
13. Quantitative structure-selectivity relationships. Comparison of the inhibition of Escherichia coli and bovine liver dihydrofolate reductase by 5-(substituted-benzyl)-2,4-diaminopyrimidines. Dietrich SW, Blaney JM, Reynolds MA, Jow PY, Hansch C. J Med Chem; 1980 Nov; 23(11):1205-12. PubMed ID: 7005446 [Abstract] [Full Text] [Related]
14. Quantitative structure-selectivity relationships. Comparison of the inhibition of Escherichia coli and bovine liver dihydrofolate reductase by 5-(substituted-benzyl)-2,4-diaminopyrimidines. Li RL, Dietrich SW, Hansch C. J Med Chem; 1981 May; 24(5):538-44. PubMed ID: 7017146 [Abstract] [Full Text] [Related]
15. A molecular model of the folate binding site of Pneumocystis carinii dihydrofolate reductase. Southerland WM. J Comput Aided Mol Des; 1994 Apr; 8(2):113-22. PubMed ID: 8064329 [Abstract] [Full Text] [Related]
16. 1H/15N HSQC NMR studies of ligand carboxylate group interactions with arginine residues in complexes of brodimoprim analogues and Lactobacillus casei dihydrofolate reductase. Morgan WD, Birdsall B, Nieto PM, Gargaro AR, Feeney J. Biochemistry; 1999 Feb 16; 38(7):2127-34. PubMed ID: 10026296 [Abstract] [Full Text] [Related]
19. Nonlinear quantitative structure-activity relationship for the inhibition of dihydrofolate reductase by pyrimidines. Hirst JD. J Med Chem; 1996 Aug 30; 39(18):3526-32. PubMed ID: 8784450 [Abstract] [Full Text] [Related]